Product Launch (Blog)

Oct, 06 2022

Global Antiviral Drugs Market is Rising Exponentially at a Healthy CAGR Owing to Rising Population of Viral Infections

Antiviral Drugs Market size is expected grow at a healthy compound annual growth rate in the forecast period of 2020 to 2027 due to the rapid advances in the formulation such as fixed dose combination and growing demand of diseases specific treatment which is primarily driving the market growth rate.

Beside this, the various emerging markets and high investment in research and development will produce lucrative opportunities for the growth of the antiviral drugs market.

Antiviral Drugs Market Scenario

According to Data Bridge Market Research the market for antiviral drugs is accelerating because of the increased population of viral infections such as respiratory syncytial virus as well as influenza.  Also the, growing pervasiveness of infectious diseases and high adoption of antiviral therapies are also expected to fuel the demand of the antiviral drugs market over the forecast period of 2020 to 2027. Whereas the, high adoption of alternative medicines will obstruct the growth of the antiviral drugs market in the above mentioned forecast period.

Now the question is which are the other regions that antiviral drugs market is targeting? Data Bridge Market Research has estimated large growth in Europe due to soaring diagnosis rate and well developed healthcare infrastructure within the region.

For more analysis on the antiviral drugs request for a briefing with our analysts

Antiviral Drugs Market Development

  • In August 2020, Dr Reddy's Laboratories had announced the launch of antiviral drug Avigan favipiravir tablets, which is presently being manufactured by Japanese drug giant Fujifilm Toyama Chemical Co, for possible treatment of mild to modest Covid-19 symptoms. The launch will help the company to enhance its presence in the market.

Antiviral Drugs Market Scope             

Antiviral drugs market is segmented on the basis of countries into the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa(MEA), Brazil, Argentina and Rest of South America as part of South America.

  • All country based analysis of antiviral drugs market is further analyzed based on maximum granularity into further segmentation. On the basis of drug class, the global antiviral drugs market is segmented into DNA polymerase inhibitors, reverse transcriptase inhibitors, protease inhibitors, m-RNA synthesis inhibitors, integrase inhibitors and others. Based on indication, the global antiviral drugs market is segmented into HIV, hepatitisherpes simplex virus, influenza and others. Route of administration segment of global antiviral drugs market is segmented into oral, topical and others. On the basis of end-users, the global antiviral drugs market is segmented into hospitals, homecare, specialty clinics and others. On the basis of distribution channel, the global antiviral drugs market has been bifurcated into hospital pharmacy, online pharmacy and retail pharmacy.
  • Antiviral drugs are the type of antimicrobials therapeutics which is used broadly in the treatment of viral infections. Some of these antiviral drugs acts on protease enzymes and stop it from cell division.

To know more about the study,

Key Pointers Covered in the Antiviral Drugs Market Industry Trends and Forecast to 2027

  • Market Size
  • Market New Sales Volumes
  • Market Replacement Sales Volumes
  • Market Installed Base
  • Market By Brands
  • Market Procedure Volumes
  • Market Product Price Analysis
  • Market Healthcare Outcomes
  • Market Cost of Care Analysis
  • Market Regulatory Framework and Changes
  • Prices and Reimbursement Analysis
  • Market Shares in Different Regions
  • Recent Developments for Market Competitors
  • Market Upcoming Applications
  • Market Innovators Study

Key Market Competitors Covered in the Report

  • Merck & Co., Inc
  • F. Hoffmann-La Roche Ltd
  • Johnson & Johnson Services, Inc
  • GlaxoSmithKline plc
  • Hetero
  • Mylan N.V
  • Aurobindo Pharma
  • Cipla Inc
  • Laurus Labs Ltd
  • Micro Labs Ltd, Inc
  • Gilead Sciences, Inc
  • Sun Pharmaceutical Industries Ltd
  • Amneal Pharmaceuticals LLC
  • Alembic Pharmaceuticals Limited
  • Lupin
  • Novartis AG
  • Zydus Pharma
  • Bausch Health 

Above are the key players covered in the report, to know about more and exhaustive list of antiviral drugs companies’ contact us

Research Methodology of Global Antiviral Drugs Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Related Reports

Browse in Healthcare Category Related Reports@

Client Testimonials